cbdMD, Inc.YCBDEarnings & Financial Report
NYSE
YCBD Q1 2026 Key Financial Metrics
Revenue
$5.0M
Gross Profit
$3.0M
Operating Profit
$-286.3K
Net Profit
$-283.1K
Gross Margin
59.8%
Operating Margin
-5.7%
Net Margin
-5.6%
YoY Growth
-1.9%
EPS
$-0.04
Financial Flow
cbdMD, Inc. Q1 2026 Financial Summary
cbdMD, Inc. reported revenue of $5.0M for Q1 2026, with a net profit of $-283.1K (-5.6% margin). Cost of goods sold was $2.0M, operating expenses totaled $3.3M.
Key Financial Metrics
| Total Revenue | $5.0M |
|---|---|
| Net Profit | $-283.1K |
| Gross Margin | 59.8% |
| Operating Margin | -5.7% |
| Report Period | Q1 2026 |
cbdMD, Inc. Annual Revenue by Year
cbdMD, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $19.2M).
| Year | Annual Revenue |
|---|---|
| 2025 | $19.2M |
| 2024 | $19.5M |
| 2023 | $24.2M |
| 2022 | $35.4M |
Income Statement
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.4M | $5.2M | $4.6M | $5.1M | $4.7M | $4.6M | $4.7M | $5.0M |
| YoY Growth | -29.9% | -15.5% | -20.2% | -4.9% | 8.5% | -11.0% | 3.6% | -1.9% |
Balance Sheet
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $14.6M | $13.8M | $10.6M | $11.5M | $10.9M | $9.9M | $10.4M | $11.8M |
| Liabilities | $11.5M | $10.8M | $8.6M | $9.8M | $10.3M | $3.8M | $3.2M | $2.8M |
| Equity | $3.1M | $3.0M | $2.0M | $1.8M | $665798 | $6.1M | $7.2M | $9.0M |
Cash Flow
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-704068 | $289779 | $167377 | $-317949 | $-189477 | $-704200 | $-240749 | $-812464 |